It is with great sadness that the InfuCare Rx team announces the loss of a dear friend and patient, Lenora “Lynn” Waltz. We have been honored with the privilege of knowing and treating Lynn for more than fifteen years. Lynn was instrumental in starting a local Myasthenia Gravis (MG) support group near Pasadena, Maryland, which ultimately became the Myasthenia Gravis Foundation of America (MGFA). Lynn was a passionate, fearless, and tremendous advocate who was a source of strength for many newly diagnosed MG patients.
ASTON, Pennsylvania, February 10, 2021 – InfuCare Rx, a leading nationwide specialty infusion provider in the treatment of acute and chronic conditions, announced this week their selection as a preferred provider in Cigna’s eviCore healthcare specialty pharmacy network. InfuCare Rx has been selected as a preferred provider based on its high quality clinical therapy management capabilities, national scope and real-time data driven outcomes reporting through its proprietary digital solution, InfuCare Rx Health. InfuCare Rx will provide a variety of specialty and non-specialty infusion services to Cigna members through eviCore healthcare. These services will include anti-infective therapy, bleeding disorders, immunoglobulin therapy (IV and subcutaneous), parenteral nutrition and specialty biologics effective February 1, 2021.
Mental illnesses are health conditions involving changes in emotion, thinking and behavior. The changes can be a combination of each condition. These conditions can be occasional or chronic and can alter someone’s ability to function daily during social, work and family activities.